Article

Steering patients toward visual rehabilitation

Ophthalmologists generally advise their patients to seek visual rehabilitation services when patients have moderate to severe glaucoma, said Mary Lou Jackson, MD.

Chicago-Ophthalmologists generally advise their patients to seek visual rehabilitation services when patients have moderate to severe glaucoma, said Mary Lou Jackson, MD.

“Patients with moderate and more severe glaucoma will likely benefit from being advised about options for visual rehabilitation,” said Dr. Jackson, director of Vision Rehabilitation Services, Massachusetts Eye and Ear Infirmary, Boston.

Comprehensive vision rehabilitation addresses the whole person because visual loss affects the whole person, she emphasized.

“Glaucoma impacts the patient’s quality of life in many ways,” she said. “That is, driving, walking, and reading are impacted, as well as the fact that just the diagnosis of glaucoma causes anxiety about blindness.”

She emphasized that visual rehabilitative services should go well beyond the use of magnifiers and should provide technologies to enhance patients’ ability to read; help patients perform independent activities of daily living; increase safety by preventing falls and helping them read eye drop prescriptions; facilitate participation in activities; and address psychosocial issues regarding the patients’ well-being, such as anxiety about Charles Bonnet syndrome visual hallucinations, which are experienced by about 30% of patients with moderate and severe glaucoma.

Ophthalmologists are an important source of help for identifying visual rehabilitation options. Dr. Jackson recommended the SmartSight patient handouts available through the American Academy of Ophthalmology website that can help patients make the most of their remaining vision.

“Just as patients with cardiac disease and stroke can obtain assessment and rehabilitation, patients with glaucoma can also,” she said.

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.